| 2024-10-28 | +40.1% | legal | SEC EDGAR | PRCT 8-K: 2.02 and (SEC Filing) |
| 2024-08-21 | +23.9% | legal | SEC EDGAR | PRCT 8-K: 8.01 (SEC Filing) |
| 2023-11-01 | +18.7% | legal | SEC EDGAR | PRCT 8-K: 2.02 and (SEC Filing) |
| 2025-08-06 | -18.4% | earnings | Seeking Alpha | Procept GAAP EPS of -$0.35 beats by $0.07, revenue of $79.2M beats by $2.96M |
| 2025-08-06 | -18.4% | legal | SEC EDGAR | PRCT 8-K: 2.02 and (SEC Filing) |
| 2023-04-27 | -17.9% | legal | SEC EDGAR | PRCT 8-K: 2.02 and (SEC Filing) |
| 2026-02-26 | -17.5% | earnings | Seeking Alpha | PROCEPT BioRobotics outlines $390M–$410M revenue target for 2026 as pricing discipline and commercial realignment reshape outlook |
| 2026-02-26 | -17.5% | earnings | Seeking Alpha | PROCEPT BioRobotics Corporation (PRCT) Q4 2025 Earnings Call Transcript |
| 2026-02-26 | -17.5% | news | Investor's Business Daily | Robotics Play Procept Biorobotics Plummets On Hard-To-Stomach Update - Investor's Business Daily |
| 2026-02-26 | -17.5% | analyst | Investing.com | Procept BioRobotics stock rating cut to Perform by Oppenheimer - Investing.com |
| 2026-02-26 | -17.5% | news | Stock Titan | Robot surgery firm targets BPH leadership and eyes prostate cancer market - Stock Titan |
| 2026-02-26 | -17.5% | analyst | Investing.com | BofA downgrades Procept BioRobotics stock rating on utilization concerns - Investing.com |
| 2026-02-26 | -17.5% | news | Quiver Quantitative | PROCEPT BioRobotics Details Growth Strategy and Financial Outlook During 2026 Investor Day Event - Quiver Quantitative |
| 2026-02-26 | -17.5% | earnings | Stocktwits | PRCT Stock Tumbles Pre-Market: BofA Questions Earnings Visibility, Cuts Target To $20 - Stocktwits |
| 2026-02-26 | -17.5% | earnings | Trefis | PROCEPT BioRobotics Stock Pre-Market (-24%) : Q4 Revenue Miss & Weak 2026 Guidance - Trefis |
| 2026-02-26 | -17.5% | analyst | Investing.com | TD Cowen reiterates Procept BioRobotics stock rating at Buy - Investing.com |
| 2026-02-26 | -17.5% | earnings | Investing.com | Piper Sandler cuts Procept BioRobotics price target on weak Q4 - Investing.com |
| 2026-02-26 | -17.5% | earnings | Investing.com UK | Piper Sandler cuts Procept BioRobotics price target on weak Q4 By Investing.com - Investing.com UK |
| 2025-08-07 | -16.6% | earnings | Seeking Alpha | PROCEPT BioRobotics outlines $325.5M 2025 revenue target amid leadership transition and margin expansion |
| 2025-08-07 | -16.6% | earnings | Seeking Alpha | PROCEPT BioRobotics Corporation (PRCT) Q2 2025 Earnings Call Transcript |
| 2026-03-02 | +16.6% | earnings | Intellectia AI | PRCT Stock News Today | Earnings, Events & Price Alerts - Intellectia AI |
| 2024-05-01 | +15.9% | legal | SEC EDGAR | PRCT 8-K: 2.02 and (SEC Filing) |
| 2026-02-28 | +14.1% | earnings | Yahoo Finance | A Look At PROCEPT BioRobotics (PRCT) Valuation After Q4 Revenue Miss And Softer 2026 Outlook - Yahoo Finance |
| 2026-02-25 | -13.6% | earnings | Seeking Alpha | Procept GAAP EPS of -$0.53 misses by $0.20, revenue of $76.4M misses by $17.3M |
| 2026-02-25 | -13.6% | legal | SEC EDGAR | PRCT 8-K: 2.02 and (SEC Filing) |
| 2026-02-25 | -13.6% | earnings | Yahoo Finance | PROCEPT BioRobotics Corporation (PRCT) Reports Q4 Loss, Lags Revenue Estimates - Yahoo Finance |
| 2026-02-25 | -13.6% | news | Stock Titan | Surgical robot firm targets $410M 2026 sales after 12,200-procedure quarter - Stock Titan |
| 2026-02-25 | -13.6% | earnings | Investing.com | Earnings call transcript: Procept Biorobotics Q4 2025 results miss, stock up - Investing.com |
| 2026-02-25 | -13.6% | earnings | GlobeNewswire | PROCEPT BioRobotics Reports Fourth Quarter 2025 Financial Results and Updates 2026 Revenue Guidance - GlobeNewswire |
| 2023-01-09 | -11.5% | legal | SEC EDGAR | PRCT 8-K: 2.02 and (SEC Filing) |
| 2026-03-10 | +10.3% | news | Investing.com | Procept Biorobotics director Desai buys PRCT shares worth $10.4m - Investing.com |
| 2022-11-03 | -10.3% | legal | SEC EDGAR | PRCT 8-K: 2.02 and (SEC Filing) |
| 2026-02-27 | +10.0% | analyst | Seeking Alpha | PROCEPT BioRobotics Corporation (PRCT) Analyst/Investor Day - Slideshow |
| 2026-02-27 | +10.0% | analyst | Investing.com | Truist cuts Procept BioRobotics stock price target on lower forecasts - Investing.com |
| 2026-02-27 | +10.0% | analyst | Seeking Alpha | PROCEPT BioRobotics Corporation (PRCT) Analyst/Investor Day - Slideshow (NASDAQ:PRCT) 2026-02-27 - Seeking Alpha |
| 2026-02-27 | +10.0% | earnings | simplywall.st | PROCEPT BioRobotics (PRCT) Quarterly Loss Deepens Challenging Bullish Margin Expansion Narrative - simplywall.st |
| 2025-11-05 | -9.9% | earnings | Seeking Alpha | Procept BioRobotics outlines $410M–$430M 2026 revenue target while accelerating utilization initiatives |
| 2025-11-05 | -9.9% | earnings | Seeking Alpha | PROCEPT BioRobotics Corporation (PRCT) Q3 2025 Earnings Call Transcript |
| 2025-11-05 | -9.9% | earnings | Yahoo Finance | PROCEPT BioRobotics (PRCT): Earnings Still Deep in Red as Losses Increase 14.1% Per Year - Yahoo Finance |
| 2025-11-05 | -9.9% | analyst | Investing.com | Procept BioRobotics stock price target lowered by TD Cowen to $50 - Investing.com |
| 2025-11-05 | -9.9% | analyst | Investing.com | Procept BioRobotics stock price target lowered to $55 at Leerink Partners - Investing.com |
| 2026-03-26 | +9.2% | news | Insider Monkey | PROCEPT BioRobotics (PRCT) Strengthens Its Case with Expanding System Base |
| 2026-03-26 | +9.2% | news | Yahoo Finance | PROCEPT BioRobotics (PRCT) Strengthens Its Case with Expanding System Base - Yahoo Finance |
| 2026-03-26 | +9.2% | news | PR Newswire | INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PROCEPT BioRobotics Corporation - PRCT - PR Newswire |
| 2026-03-26 | +9.2% | news | GlobeNewswire | PRCT: GUIDED $325.5M, HID PRICING HEADWIND -- LEVI & KORSINSKY, LLP INVESTIGATES - GlobeNewswire |
| 2025-04-24 | -8.6% | earnings | Seeking Alpha | Procept biorobotics outlines 2025 growth targets with $323M revenue guidance |
| 2025-04-24 | -8.6% | earnings | Seeking Alpha | PROCEPT BioRobotics Corporation (PRCT) Q1 2025 Earnings Call Transcript |
| 2025-04-24 | -8.6% | earnings | Seeking Alpha | Procept beats Q1 estimates |
| 2025-04-24 | -8.6% | legal | SEC EDGAR | PRCT 8-K: 2.02 and (SEC Filing) |
| 2025-12-02 | +8.6% | news | Seeking Alpha | PROCEPT BioRobotics Corporation (PRCT) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript |
| 2025-07-25 | -8.2% | executive | Seeking Alpha | Procept BioRobotics down after CEO retirement |
| 2025-07-25 | -8.2% | legal | SEC EDGAR | PRCT 8-K: 2.02, 5.02, 7.01 (SEC Filing) |
| 2025-07-25 | -8.2% | executive | Seeking Alpha | Procept BioRobotics stock down on CEO exit (PRCT:NASDAQ) - Seeking Alpha |
| 2022-01-04 | -7.8% | legal | SEC EDGAR | PRCT 8-K: 1.01, 5.02 (SEC Filing) |
| 2026-03-30 | -7.7% | news | Seeking Alpha | Procept BioRobotics: An Undervalued Surgical Robotics Growth Story |
| 2026-03-30 | -7.7% | news | Seeking Alpha | PROCEPT BioRobotics: An Undervalued Surgical Robotics Growth Story (NASDAQ:PRCT) - Seeking Alpha |
| 2025-11-04 | -7.6% | earnings | Seeking Alpha | Procept GAAP EPS of -$0.38 beats by $0.04, revenue of $83.3M beats by $2.53M |
| 2025-11-04 | -7.6% | legal | SEC EDGAR | PRCT 8-K: 2.02 and (SEC Filing) |
| 2025-11-04 | -7.6% | earnings | Yahoo Finance | PROCEPT BioRobotics Corporation (PRCT) Reports Q3 Loss, Beats Revenue Estimates - Yahoo Finance |
| 2025-11-04 | -7.6% | earnings | GlobeNewswire | PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance - GlobeNewswire |
| 2025-11-04 | -7.6% | earnings | Investing.com | Earnings call transcript: PROCEPT BioRobotics Q3 2025 beats revenue forecasts - Investing.com |
| 2026-04-14 | +7.4% | earnings | Motley Fool | PROCEPT BioRobotics (PRCT) Earnings Transcript |
| 2026-04-14 | +7.4% | earnings | MarketBeat | Baillie Gifford & Co. Purchases 157,147 Shares of PROCEPT BioRobotics Corporation $PRCT - MarketBeat |
| 2026-04-14 | +7.4% | earnings | The Globe and Mail | PROCEPT BioRobotics (PRCT) Earnings Transcript - The Globe and Mail |
| 2023-07-27 | -7.0% | legal | SEC EDGAR | PRCT 8-K: 2.02 and (SEC Filing) |
| 2025-12-20 | +6.2% | news | Trefis | PROCEPT BioRobotics Stock Drop Looks Sharp, But How Deep Can It Go? - Trefis |
| 2024-08-01 | -6.1% | legal | SEC EDGAR | PRCT 8-K: 2.02 and (SEC Filing) |
| 2026-04-04 | -5.8% | earnings | MarketBeat | PROCEPT BioRobotics Corporation $PRCT Shares Acquired by SG Americas Securities LLC - MarketBeat |
| 2026-04-03 | -5.8% | news | Cổng thông tin điện tử tỉnh Lào Cai | PRCT Stock Analysis: PROCEPT BioRobotics down 0.95pct to 25.12 in medtech trading - Cổng thông tin điện tử tỉnh Lào Cai |
| 2025-09-02 | -5.6% | news | DirectorsTalk Interviews | PROCEPT BioRobotics (PRCT) Stock Analysis: A Promising 64.85% Upside Potential for the Surgical Robotics Leader - DirectorsTalk Interviews |
| 2025-09-30 | -5.5% | legal | DirectorsTalk Interviews | PROCEPT BioRobotics (PRCT) Stock Analysis: Exploring a 79.78% Potential Upside in the Medical Device Sector - DirectorsTalk Interviews |
| 2025-02-26 | +5.2% | earnings | Seeking Alpha | PROCEPT BioRobotics Corporation (PRCT) Q4 2024 Earnings Call Transcript |
| 2025-02-26 | +5.2% | earnings | Seeking Alpha | PROCEPT BioRobotics Corporation 2024 Q4 - Results - Earnings Call Presentation |
| 2021-11-04 | -5.2% | legal | SEC EDGAR | PRCT 8-K: 2.02 and (SEC Filing) |
| 2025-12-16 | -5.1% | earnings | DirectorsTalk Interviews | PROCEPT BioRobotics (PRCT) Stock Analysis: Eyeing a 41% Upside with Robust Revenue Growth - DirectorsTalk Interviews |
| 2025-02-25 | +5.0% | earnings | Seeking Alpha | Procept GAAP EPS of -$0.35 misses by $0.02, revenue of $68.24M beats by $1.45M |
| 2025-02-25 | +5.0% | legal | SEC EDGAR | PRCT 8-K: 2.02 and (SEC Filing) |
| 2025-02-11 | -4.8% | news | Seeking Alpha | SA Asks: Which small/mid-cap AI stocks should investors be watching? |
| 2026-01-26 | +4.8% | earnings | Quiver Quantitative | PROCEPT BioRobotics to Report Q4 2025 Financial Results and Host Investor Day Event in February 2026 - Quiver Quantitative |
| 2026-03-24 | -4.4% | legal | PR Newswire | Sonder Capital Closes its Second Fund and Announces Participation from Major Healthcare Systems |
| 2023-06-02 | -4.2% | legal | SEC EDGAR | PRCT 8-K: 1.01, 2.03 (SEC Filing) |
| 2026-03-27 | +3.9% | analyst | Simply Wall St. | EAU Upgrade Puts Aquablation And PROCEPT BioRobotics In Focus |
| 2026-03-27 | +3.9% | news | Stock Titan | Vanguard Realigns Reporting; PROCEPT BioRobotics (PRCT) Beneficial Ownership 0% - Stock Titan |
| 2025-10-20 | +3.9% | earnings | Insider Monkey | Truist Lowers PT on PROCEPT BioRobotics Corporation (PRCT) to $50 From $64, Keeps a Buy Rating - Insider Monkey |
| 2026-04-17 | +3.9% | earnings | simplywall.st | Assessing PROCEPT BioRobotics (PRCT) Valuation After Strong Q3 2025 Update And 2026 Outlook - simplywall.st |
| 2025-11-03 | +3.9% | earnings | Seeking Alpha | Procept Q3 2025 Earnings Preview |
| 2026-01-08 | -3.9% | analyst | Yahoo Finance | Truist Maintains Buy Rating on Procept BioRobotics (PRCT) Amid MedTech Sector Rotation - Yahoo Finance |
| 2025-10-06 | -3.8% | news | Seeking Alpha | Procept BioRobotics: A Strong Challenger Positioned To Be A Future Leader |
| 2025-10-06 | -3.8% | news | Seeking Alpha | Procept BioRobotics: A Strong Challenger Positioned To Be A Future Leader (PRCT) - Seeking Alpha |
| 2026-03-04 | -3.6% | analyst | Seeking Alpha | PROCEPT BioRobotics Corporation (PRCT) Analyst/Investor Day Transcript |
| 2025-08-21 | +3.6% | news | Yahoo Finance | PROCEPT BioRobotics (PRCT) Outlook Adjusted as System Replacement Forecasts Shift - Yahoo Finance |
| 2026-04-16 | -3.5% | earnings | simplywall.st | PROCEPT BioRobotics (PRCT) Is Up 7.5% After Raising 2026 Revenue Outlook And Sharpening Growth Focus - simplywall.st |
| 2026-04-16 | -3.5% | earnings | MarketBeat | PROCEPT BioRobotics (PRCT) Projected to Post Earnings on Thursday - MarketBeat |
| 2026-03-23 | -3.4% | analyst | GlobeNewswire | EAU Guidelines Upgrade Aquablation® Therapy to Strong Surgical Recommendation for BPH |
| 2026-03-23 | -3.4% | news | Stock Titan | Europe's top urology guide strongly backs Aquablation for BPH - Stock Titan |
| 2026-04-23 | -3.4% | news | Stock Traders Daily | Precision Trading with Procept Biorobotics Corporation (PRCT) Risk Zones - Stock Traders Daily |
| 2026-04-23 | -3.4% | earnings | MarketBeat | PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat |
| 2026-04-09 | -3.3% | news | GlobeNewswire | PROCEPT BioRobotics® to Report First Quarter 2026 Financial Results on April 29, 2026 |
| 2026-04-09 | -3.3% | earnings | Stock Titan | PROCEPT BioRobotics sets April 29 earnings report and investor call - Stock Titan |
| 2026-04-09 | -3.3% | news | Cổng thông tin điện tử tỉnh Lào Cai | Can PROCEPT (PRCT) Stock Double in 2026 | Price at $23.35, Down 2.18% - Correlation Analysis - Cổng thông tin điện tử tỉnh Lào Cai |
| 2025-08-14 | +3.2% | news | Seeking Alpha | Procept BioRobotics: Increasing Average Selling Price, Initiate At Buy |
| 2025-08-14 | +3.2% | news | Seeking Alpha | Procept BioRobotics: Increasing Average Selling Price, Initiate At Buy (NASDAQ:PRCT) - Seeking Alpha |
| 2025-08-14 | +3.2% | news | Stock Titan | PRCT Form 4: Frederic Moll Increases Stake to 863,159 Shares - Stock Titan |
| 2024-07-19 | +3.2% | legal | SEC EDGAR | PRCT 8-K: 5.02 and (SEC Filing) |
| 2025-10-24 | +3.0% | executive | The Motley Fool | Is Procept BioRobotics Stock a Buy After Investment Company Chicago Capital Scoops Up Nearly 1 Million Shares? - The Motley Fool |
| 2026-04-08 | -2.8% | news | Zacks | Inogen (INGN) Surges 6.9%: Is This an Indication of Further Gains? |
| 2026-03-29 | -2.7% | earnings | MarketBeat | PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Given Average Rating of "Hold" by Brokerages - MarketBeat |
| 2026-03-03 | +2.7% | analyst | TipRanks | Procept BioRobotics price target lowered to $30 from $47 at Truist |
| 2026-03-03 | +2.7% | analyst | Yahoo Finance | Procept BioRobotics price target lowered to $30 from $47 at Truist - Yahoo Finance |
| 2026-04-22 | -2.7% | executive | Quiver Quantitative | PROCEPT BioRobotics Corp ($PRCT) CEO 2025 Pay Revealed - Quiver Quantitative |
| 2026-04-22 | -2.7% | news | Stock Titan | PROCEPT BioRobotics (NASDAQ: PRCT) details 2026 virtual meeting and pay vote - Stock Titan |
| 2026-04-22 | -2.7% | news | Quiver Quantitative | PRCT | PROCEPT BioRobotics Corporation Common Executive Compensation - Quiver Quantitative |
| 2026-04-22 | -2.7% | earnings | Cổng thông tin điện tử tỉnh Lào Cai | PRCT (PROCEPT BioRobotics Corporation) posts 37.2 percent year over year revenue growth, shares fall 4.48 percent on steep EPS miss. - Product Revenue - Cổng thông tin điện tử tỉnh Lào Cai |
| 2025-08-08 | -2.7% | analyst | simplywall.st | PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Just Reported, And Analysts Assigned A US$65.75 Price Target - simplywall.st |
| 2026-04-18 | +2.5% | earnings | MarketBeat | Chicago Capital LLC Has $37.47 Million Holdings in PROCEPT BioRobotics Corporation $PRCT - MarketBeat |
| 2025-09-26 | -2.3% | news | simplywall.st | Is PROCEPT BioRobotics (NASDAQ:PRCT) A Risky Investment? - simplywall.st |
| 2025-05-19 | +2.1% | news | Seeking Alpha | PROCEPT BioRobotics: A 'Razor And Razor Blade' Business Model |
| 2025-12-08 | -2.0% | analyst | Investing.com | Procept BioRobotics stock downgraded by BofA on slowing growth - Investing.com |
| 2022-10-11 | +2.0% | legal | SEC EDGAR | PRCT 8-K: 1.01, 1.02, 2.03 (SEC Filing) |
| 2023-02-28 | +2.0% | legal | SEC EDGAR | PRCT 8-K: 2.02 and (SEC Filing) |
| 2023-08-04 | -1.8% | legal | SEC EDGAR | PRCT 8-K: 8.01 and (SEC Filing) |
| 2025-02-24 | +1.7% | earnings | Seeking Alpha | Procept Q4 2024 Earnings Preview |
| 2025-12-12 | +1.4% | analyst | Investing.com | UBS initiates Procept BioRobotics stock with Buy rating on utilization growth - Investing.com |
| 2025-07-09 | +1.4% | news | simplywall.st | Insiders At PROCEPT BioRobotics Sold US$12m In Stock, Alluding To Potential Weakness - simplywall.st |
| 2026-02-05 | -1.3% | news | Investing.com | Procept Biorobotics stock hits 52-week low at 27.79 USD - Investing.com |
| 2025-12-24 | -1.3% | earnings | Sahm | How Investors Are Reacting To PROCEPT BioRobotics (PRCT) UBS Coverage Initiation And 2027 Profitability Outlook - Sahm |
| 2025-08-09 | +1.1% | news | simplywall.st | What You Can Learn From PROCEPT BioRobotics Corporation's (NASDAQ:PRCT) P/S After Its 34% Share Price Crash - simplywall.st |
| 2024-02-27 | +1.1% | legal | SEC EDGAR | PRCT 8-K: 2.02 and (SEC Filing) |
| 2026-02-12 | -1.0% | news | Yahoo Finance | Wall Street Has a Positive Opinion on PROCEPT BioRobotics (PRCT), Here’s Why - Yahoo Finance |
| 2026-01-27 | +1.0% | news | Yahoo Finance | A Look At PROCEPT BioRobotics (PRCT) Valuation After Mixed Recent Share Price Returns - Yahoo Finance |
| 2022-05-05 | -1.0% | legal | SEC EDGAR | PRCT 8-K: 2.02 and (SEC Filing) |
| 2025-12-22 | +1.0% | analyst | Yahoo Finance | Promising Growth Forecasts Leading to Analysts’ Optimism for Procept Biorobotics (PRCT) - Yahoo Finance |
| 2026-03-09 | -0.9% | news | Investing.com Nigeria | Procept Biorobotics director Desai buys PRCT shares worth $10.4m By Investing.com - Investing.com Nigeria |
| 2026-03-09 | -0.9% | news | Stock Titan | Kestrel Fund tied to PROCEPT BioRobotics (PRCT) director buys 426K shares - Stock Titan |
| 2026-03-09 | -0.9% | news | Investing.com | Alaleh Nouri, EVP at Procept Biorobotics, sells $163k in shares - Investing.com |
| 2024-10-31 | +0.8% | legal | SEC EDGAR | PRCT 8-K: 8.01 and (SEC Filing) |
| 2022-03-08 | -0.7% | legal | SEC EDGAR | PRCT 8-K: 2.02 and (SEC Filing) |
| 2024-12-02 | +0.7% | analyst | Seeking Alpha | Morgan Stanley bullish on medtech in 2025, upgrades 5 stocks |
| 2021-10-26 | -0.6% | legal | SEC EDGAR | PRCT 8-K: 5.02 and (SEC Filing) |
| 2025-07-21 | +0.5% | legal | Quiver Quantitative | PROCEPT BioRobotics to Announce Second Quarter 2025 Financial Results on August 6, 2025 - Quiver Quantitative |
| 2026-03-19 | +0.5% | news | Stock Titan | PROCEPT BioRobotics (NASDAQ: PRCT) EVP completes 5,363-share planned sale - Stock Titan |
| 2026-03-19 | +0.5% | news | Investing.com | Alaleh Nouri, EVP at Procept Biorobotics, sells $139k in PRCT stock - Investing.com |
| 2026-03-19 | +0.5% | news | Stock Titan | PROCEPT BioRobotics (PRCT) CLO sells 304 shares to cover RSU taxes - Stock Titan |
| 2026-03-19 | +0.5% | executive | Stock Titan | PROCEPT (NASDAQ: PRCT) CFO sells 706 shares for tax withholding - Stock Titan |
| 2026-03-19 | +0.5% | news | Investing.com | Nouri, Procept EVP, CLO, sold $8.6k in PRCT stock - Investing.com |
| 2026-03-19 | +0.5% | news | Stock Titan | Alalah Nouri (NASDAQ: PRCT) files Form 144 to sell vested RSUs - Stock Titan |
| 2025-09-18 | -0.4% | legal | SEC EDGAR | PRCT 8-K: 5.02 and (SEC Filing) |
| 2026-03-12 | -0.3% | expansion | GlobeNewswire | PROCEPT BioRobotics® Announces International Launch of the HYDROS® Robotic System, Expanding Global Access to AI-Enabled Aquablation® Therapy |
| 2026-03-12 | -0.3% | expansion | Stock Titan | AI-guided BPH treatment robot launches in UK for men on long-term meds - Stock Titan |
| 2026-03-12 | -0.3% | news | GuruFocus | FMR LLC Reduces Stake in PROCEPT BioRobotics Corp by 65.40% - GuruFocus |
| 2026-03-12 | -0.3% | expansion | Investing.com | PROCEPT BioRobotics launches HYDROS system in UK - Investing.com |
| 2025-10-08 | +0.3% | news | Yahoo Finance | PROCEPT BioRobotics (PRCT): Evaluating Valuation After Sharp Recent Share Price Declines - Yahoo Finance |
| 2025-03-11 | +0.3% | earnings | Seeking Alpha | Procept BioRobotics: Strong Growth, But Profitability Seems Far Away |
| 2025-10-15 | +0.3% | earnings | Stock Titan | Q3 2025 results on Nov. 4 — PROCEPT BioRobotics to Host 4:30 p.m. ET Conference Call and Webcast - Stock Titan |
| 2025-10-15 | +0.3% | news | Quiver Quantitative | PROCEPT BioRobotics to Report Third Quarter 2025 Financial Results on November 4, 2025 - Quiver Quantitative |
| 2022-01-11 | +0.3% | legal | SEC EDGAR | PRCT 8-K: 2.02 (SEC Filing) |
| 2026-02-23 | +0.3% | earnings | Seeking Alpha | Procept Q4 2025 Earnings Preview |
| 2026-02-23 | +0.3% | earnings | Stock Titan | Inclement weather delays PROCEPT BioRobotics Q4 call, Investor Day - Stock Titan |
| 2023-09-12 | -0.2% | legal | SEC EDGAR | PRCT 8-K: 8.01 (SEC Filing) |
| 2026-02-24 | +0.2% | news | Yahoo Finance | PROCEPT BioRobotics Corporation (PRCT): A Bull Case Theory - Yahoo Finance |
| 2026-02-24 | +0.2% | news | Insider Monkey | PROCEPT BioRobotics Corporation (PRCT): A Bull Case Theory - Insider Monkey |
| 2024-04-19 | +0.2% | legal | SEC EDGAR | PRCT 8-K: 5.02 (SEC Filing) |
| 2026-03-06 | +0.1% | analyst | MT Newswires | Baird Initiates PROCEPT BioRobotics at Neutral With $30 Price Target |
| 2026-03-06 | +0.1% | news | Seeking Alpha | PROCEPT BioRobotics Corporation (PRCT) Presents at TD Cowen 46th Annual Health Care Conference Transcript |
| 2026-03-06 | +0.1% | legal | SEC EDGAR | PRCT 8-K: 5.02 and (SEC Filing) |
| 2026-03-06 | +0.1% | analyst | Investing.com | Baird initiates Procept BioRobotics stock rating at Neutral - Investing.com |
| 2026-03-06 | +0.1% | news | TipRanks | PROCEPT BioRobotics Adds Independent Director to Audit Committee - TipRanks |
| 2026-04-26 | — | earnings | MarketBeat | 59,200 Shares in PROCEPT BioRobotics Corporation $PRCT Bought by B. Metzler seel. Sohn & Co. AG - MarketBeat |
| 2026-04-25 | — | earnings | MarketBeat | PROCEPT BioRobotics (NASDAQ:PRCT) Rating Increased to Sell at Wall Street Zen - MarketBeat |
| 2026-04-24 | — | news | Stock Titan | PROCEPT BioRobotics (NASDAQ: PRCT) executive discloses initial stock and option stakes - Stock Titan |
| 2026-04-24 | — | news | The Motley Fool | Chicago Capital Doubles Down on PROCEPT BioRobotics, Adds $27 Million in Stock - The Motley Fool |
| 2026-04-24 | — | news | The Globe and Mail | Chicago Capital Doubles Down on PROCEPT BioRobotics, Adds $27 Million in Stock - The Globe and Mail |